Alembic recalls 4mg extended-release fesoterodine tablets due to diester impurity levels exceeding safety limits. This may pose health risks. Check your prescription bottle for NDC 62332-175-30 and lot number 2405006633.
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Take action
Contact the company
📍Recalling firmAlembic Pharmaceuticals LimitedFormulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol · Panchmahal, India
✎ GovInfoNow plain-language explainer
Alembic is recalling 4mg extended-release fesoterodine tablets because they contain too much diester impurity. This could cause health issues if taken as directed. The recall applies to prescription bottles with specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31738-alembic-fesoterodine-tablets-recall-diester-impurity-risk.
“Alembic Fesoterodine Tablets Recall: Diester Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31738-alembic-fesoterodine-tablets-recall-diester-impurity-risk. Based on FDA recall #D-0156-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0156-2026%22&limit=1).
Alembic Pharmaceuticals Limited voluntarily recalled one lot of Fesoterodine Fumarate, Extended-release Tablets, 4 mg, due to failed impurity specifications, the FDA said on Oct. 10, 2025. The recall affects 4,884 bottles distributed nationwide.
The hazard is failed impurities and degradation specifications due to levels of 'Diester Impurity' exceeding the specification limit. The FDA's FAERS database contains 386 adverse-event reports naming this product, including 347 marked serious and 33 listing a death.
Context
GovInfoNow's records show Alembic Pharmaceuticals Limited has had six other recalls since June 10, 2020. Recent similar recalls include the Alembic Fesoterodine Tablets Recall on Dec. 16, 2025, and the Alembic Doxepin Capsules Recall on July 25, 2025. Other recent recalls of similar products include the Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (Jan. 21, 2026), the Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026), and the Sun Pharmaceutical Fexofenadine 180mg Tablets Recall (June 1, 2026).
How to tell if you have this one
Check your prescription bottle for the NDC code 62332-175-30 and lot number 2405006633. The expiration date is March 31, 2026. This product is only available by prescription.
Brand
Alembic
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Look for the NDC code 62332-175-30 and lot number 2405006633 on the prescription bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 47 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0156-2026 (October 10, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0156-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.